Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Enovix’s SEC disclosures can feel like navigating a lab manual. The company’s silicon-lithium battery platform, BreakFlow safety layer, and orthogonal cell architecture introduce technical details that stretch a single 10-K well past 250 pages. If you are searching for “Enovix SEC filings explained simply” or wondering where the capital for its new manufacturing lines is coming from, you are not alone.
Stock Titan bridges that gap. Our AI-powered summaries extract the numbers and narratives that matter—from Form 4 insider transactions in real time to each Enovix quarterly earnings report 10-Q filing. Type a natural question such as “understanding Enovix SEC documents with AI” and instantly see R&D spend trends, factory yield updates, and customer concentration data. We monitor every Enovix 8-K material events explained notice, flagging supply-chain shifts the moment they hit EDGAR, and track Enovix executive stock transactions Form 4 so you can spot buying or selling before the market digests it.
Whether you need an Enovix annual report 10-K simplified to grasp long-term production targets, an Enovix proxy statement executive compensation breakdown, or an Enovix earnings report filing analysis that highlights gross-margin progress, our platform delivers. You’ll also find a concise timeline of Enovix insider trading Form 4 transactions, interactive charts comparing quarter-over-quarter CapEx, and alert tools for “Enovix Form 4 insider transactions real-time.” Save time, understand the technology risks, and make informed decisions—without diving into every footnote.
Enovix (ENVX) reported a Form 4 for COO Ajay Marathe. On 11/08/2025, 1,490 shares were withheld (Code F) to cover taxes upon RSU vesting at $9.56 per share.
After the transaction, beneficial ownership stands at 993,856 shares. This includes 757,702 shares issuable from RSUs and 33,170 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix (ENVX) reported an insider transaction by its Chief Legal Officer on a Form 4. On November 8, 2025, 934 shares of common stock were withheld at $9.56 to cover taxes upon the vesting of restricted stock units (Transaction Code F). Following the transaction, the reporting person directly beneficially owned 424,035 shares.
Holdings include 307,469 shares issuable upon the settlement of RSUs and 20,786 vested PRSUs, with 50% scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix (ENVX) President & CEO Raj Talluri reported a routine tax-withholding transaction. On November 8, 2025, 4,292 shares of common stock were withheld (Code F) at $9.56 to satisfy taxes upon RSU vesting. Following the transaction, he beneficially owned 2,312,927 shares, held directly.
This total includes 1,707,626 shares issuable upon settlement of RSUs and 95,551 vested PRSUs, with 50% scheduled to release on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix reported Q3 2025 results, showing revenue of $7.99 million and a gross profit of $1.40 million. Operating loss was $46.97 million, and net loss was $53.71 million. Year‑to‑date revenue reached $20.56 million with a net loss of $121.75 million.
Liquidity strengthened during the quarter: cash and cash equivalents were $335.50 million, with short‑term investments of $223.32 million and long‑term investments of $89.45 million. The company issued $360.0 million of 2030 convertible senior notes and purchased capped calls for $45.29 million. Warrant exercises generated $232.11 million in gross proceeds, and Enovix repurchased 5,437,556 shares for $58.39 million.
Total assets were $913.71 million and long‑term debt, net, was $518.35 million. Shares outstanding were 215,816,004 as of November 3, 2025. Management states current cash, cash equivalents and investments are expected to meet anticipated needs for at least the next twelve months.
Enovix Corporation furnished an update on its third-quarter 2025 results. The company announced that it issued a press release with financial results for the quarter, and attached it as Exhibit 99.1.
The disclosure was furnished under Item 2.02 and is not deemed “filed” for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless specifically referenced.
Enovix (ENVX) reported an insider equity transaction by its Chief Legal Officer, who had shares withheld to cover taxes tied to restricted stock unit (RSU) vesting. On October 24, 2025, 2,216 shares of common stock were withheld at a price of $12.32 under transaction code “F.”
Following the transaction, the officer beneficially owns 424,969 shares. This includes 309,236 shares issuable upon future RSU vesting and settlement, and 20,786 vested performance RSUs, with 50% scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027. Each RSU and PRSU represents a contingent right to receive one share of common stock.
Enovix (ENVX) reported an insider transaction by President and CEO and Director Raj Talluri tied to restricted stock unit (RSU) vesting. On 10/18/2025, a Form 4 shows a code F transaction reflecting the withholding of 17,618 shares of common stock at $11.21 to satisfy tax obligations from RSU vesting.
Following the transaction, Talluri beneficially owns 2,317,219 shares directly. This figure includes 1,715,747 shares issuable upon settlement of RSUs granted to him and 95,551 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027. Each RSU and PRSU represents a contingent right to receive one share upon settlement.
Enovix Corporation (ENVX) reported an insider transaction by Chief Operating Officer Ajay Marathe. On October 14, 2025, 7,338 shares of common stock were withheld to satisfy tax obligations tied to RSU vesting, recorded as Code F at $12.87 per share.
After this transaction, Marathe beneficially owned 995,346 shares directly. His holdings include 760,521 shares issuable upon RSU settlement and 33,170 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix (ENVX) officer Kristina Truong reported Form 4 transactions tied to tax withholding on vested RSUs. On October 10, 2025, 252 shares were withheld at $12.07 (Code F). On October 13, 2025, 1,013 shares were withheld at $13.02 (Code F).
Following these transactions, beneficial ownership stands at 197,734 shares. The holdings include 157,865 shares issuable upon RSU vesting and 4,978 vested PRSUs, with 50% scheduled for release on March 2, 2026 and the remaining 50% on March 1, 2027.
Enovix (ENVX) reporting officer Ajay Marathe disclosed transactions on